Wide spread of OXA-23-producing carbapenem-resistant Acinetobacter baumannii belonging to clonal complex II in different hospitals in Lebanon

International Journal of Infectious Diseases

Volumn 52, Issue , 2016, Pages 29-36

  Al Atrouni, Ahmad ^a,b   Hamze, Monzer ^a   Jisr, Tamima ^c   Lemarié, Carole ^d   Eveillard, Matthieu ^b,d   Joly Guillou, Marie Laure ^b,d   Kempf, Marie ^b,d  

^a LEBANESE UNIVERSITY   (Lebanon)

^b UNIVERSITÉ D'ANGERS   (France)

^c MAKASSED GENERAL HOSPITAL   (Lebanon)

^d ANGERS UNIVERSITY HOSPITAL   (France)

Author keywords

Acinetobacter baumannii; Carbapenem resistance; Clonal complex II; Lebanon; OXA 23

Indexed keywords

AMIKACIN; BETA LACTAMASE; BETA LACTAMASE OXA 23; CARBAPENEM; CARBAPENEMASE; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; DOXYCYCLINE; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; RIFAMPICIN; SULFAMETHOXAZOLE; TICARCILLIN; TIGECYCLINE; TIMENTIN; TOBRAMYCIN; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA-LACTAMASE OXA-23; CARBAPENEM DERIVATIVE;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CARBAPENEM RESISTANT ACINETOBACTER BAUMANNII; CATHETER; CATHETER INFECTION; CLONE; DISK DIFFUSION; FEMALE; HOSPITAL; HUMAN; LEBANON; MAJOR CLINICAL STUDY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MICROBIAL POPULATION DYNAMICS; MIDDLE AGED; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; MULTILOCUS SEQUENCE TYPING; NONHUMAN; POLYMERASE CHAIN REACTION; POPULATION STRUCTURE; PULSED FIELD GEL ELECTROPHORESIS; RPOB GENE; VERY ELDERLY; YOUNG ADULT; ACINETOBACTER INFECTIONS; DRUG EFFECTS; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; CARBAPENEMS; ELECTROPHORESIS, GEL, PULSED-FIELD; HOSPITALS; HUMANS; LEBANON; MICROBIAL SENSITIVITY TESTS; MOLECULAR EPIDEMIOLOGY; MULTILOCUS SEQUENCE TYPING; POLYMERASE CHAIN REACTION;

EID: 84994043999     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2016.09.017     Document Type: Article

References (40)

1. 1 Kempf, M., Rolain, J.M., Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options. Int J Antimicrob Agents 39 (2012), 105–114.
2. 2 McConnell, M.J., Actis, L., Pachón, J., Acinetobacter baumannii: human infections, factors contributing to pathogenesis and animal models. FEMS Microbiol Rev 37 (2013), 130–155.
3. 3 Reddy, T., Chopra, T., Marchaim, D., Pogue, J.M., Alangaden, G., Salimnia, H., et al. Trends in antimicrobial resistance of Acinetobacter baumannii isolates from a metropolitan Detroit health system. Antimicrob Agents Chemother 54 (2010), 2235–2238.
4. 4 Magiorakos, A.P., Srinivasan, A., Carey, R.B., Carmeli, Y., Falagas, M.E., Giske, C.G., et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18 (2012), 268–281.
5. 5 Imperi, F., Antunes, L.C., Blom, J., Villa, L., Iacono, M., Visca, P., et al. The genomics of Acinetobacter baumannii: insights into genome plasticity, antimicrobial resistance and pathogenicity. IUBMB Life 63 (2011), 1068–1074.
6. 6 Potron, A., Poirel, L., Nordmann, P., Emerging broad-spectrum resistance in Pseudomonas aeruginosa and Acinetobacter baumannii: mechanisms and epidemiology. Int J Antimicrob Agents 45:6 (2015), 568–585.
7. 7 Chamoun, K., Farah, M., Araj, G., Daoud, Z., Moghnieh, R., Salameh, P., et al. Surveillance of antimicrobial resistance in Lebanese hospitals: retrospective nationwide compiled data. Int J Infect Dis 46 (2016), 64–70.
8. 8 Zarrilli, R., Pournaras, S., Giannouli, M., Tsakris, A., Global evolution of multidrug-resistant Acinetobacter baumannii clonal lineages. Int J Antimicrob Agents 41 (2013), 11–19.
9. 9 Ying, J., Lu, J., Zong, L., Li, A., Pan, R., Cheng, C., et al. Molecular epidemiology and characterization of genotypic analysis of Acinetobacter baumannii strains isolates from south China. Jpn J Infect Dis 69:3 (2015), 180–185.
10. 10 Rafei, R., Kempf, M., Eveillard, M., Dabboussi, F., Hamze, M., Joly-Guillou, M.L., Current molecular methods in epidemiological typing of Acinetobacter baumannii. Future Microbiol 9 (2014), 1179–1194.
11. 11 Diancourt, L., Passet, V., Nemec, A., Dijkshoorn, L., Brisse, S., The population structure of Acinetobacter baumannii: expanding multiresistant clones from an ancestral susceptible genetic pool. PLoS One, 5, 2010, e10034.
12. 12 Rafei, R., Dabboussi, F., Hamze, M., Eveillard, M., Lemarié, C., Gaultier, M.P., et al. Molecular analysis of Acinetobacter baumannii strains isolated in Lebanon using four different typing methods. PLoS One, 9, 2014, e115969.
13. 13 Rafei, R., Pailhoriès, H., Hamze, M., Eveillard, M., Mallat, H., Dabboussi, F., et al. Molecular epidemiology of Acinetobacter baumannii in different hospitals in Tripoli, Lebanon using blaOXA-51-like sequence based typing. BMC Microbiol, 15, 2015, 103.
14. 14 Gogou, V., Pournaras, S., Giannouli, M., Voulgari, E., Piperaki, E.T., Zarrilli, R., et al. Evolution of multidrug-resistant Acinetobacter baumannii clonal lineages: a 10 year study in Greece (2000-09). J Antimicrob Chemother 66 (2011), 2767–2772.
15. 15 Talbot, G.H., Bradley, J., Edwards, J.E., Gilbert, D., Scheld, M., Bartlett, J.G., et al. Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America. Clin Infect Dis 42 (2006), 657–668.
16. 16 Maragakis, L.L., Tucker, M.G., Miller, R.G., Carroll, K.C., Perl, T.M., Incidence and prevalence of multidrug-resistant Acinetobacter using targeted active surveillance cultures. JAMA 299 (2008), 2513–2514.
17. 17 Boucher, H.W., Talbot, G.H., Bradley, J.S., Edwards, J.E., Gilbert, D., Rice, L.B., et al. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis 48 (2009), 1–12.
18. 18 Dizbay, M., Tunccan, O.G., Sezer, B.E., Hizel, K., Nosocomial imipenem-resistant Acinetobacter baumannii infections: epidemiology and risk factors. Scand J Infect Dis 42 (2010), 741–746.
19. 19 Doi, Y., Husain, S., Potoski, B.A., McCurry, K.R., Paterson, D.L., Extensively drug-resistant Acinetobacter baumannii. Emerg Infect Dis 15 (2009), 980–982.
20. 20 Metan, G., Sariguzel, F., Sumerkan, B., Factors influencing survival in patients with multi-drug-resistant Acinetobacter bacteraemia. Eur J Intern Med 20 (2009), 540–544.
21. 21 Al-Sultan, A.A., Evans, B.A., Aboulmagd, E., Al-Qahtani, A.A., Bohol, M.F., Al-Ahdal, M.N., et al. Dissemination of multiple carbapenem-resistant clones of Acinetobacter baumannii in the Eastern District of Saudi Arabia. Front Microbiol, 6, 2015, 634.
22. 22 Principe, L., Piazza, A., Giani, T., Bracco, S., Caltagirone, M.S., Arena, F., et al. Epidemic diffusion of OXA-23-producing Acinetobacter baumannii isolates in Italy: results of the first cross-sectional countrywide survey. J Clin Microbiol 52 (2014), 3004–3010.
23. 23 Kallen, A.J., Srinivasan, A., Current epidemiology of multidrug-resistant Gram-negative bacilli in the United States. Infect Control Hosp Epidemiol 31:Suppl 1 (2010), S51–S54.
24. 24 Hammoudi, D., Moubareck, C.A., Hakime, N., Houmani, M., Barakat, A., Najjar, Z., et al. Spread of imipenem-resistant Acinetobacter baumannii co-expressing OXA-23 and GES-11 carbapenemases in Lebanon. Int J Infect Dis 36 (2015), 56–61.
25. 25 Luo, T.L., Rickard, A.H., Srinivasan, U., Kaye, K.S., Foxman, B., Association of blaOXA-23 and bap with the persistence of Acinetobacter baumannii within a major healthcare system. Front Microbiol, 6, 2015, 182.
26. 26 Fouad, M., Attia, A.S., Tawakkol, W.M., Hashem, A.M., Emergence of carbapenem-resistant Acinetobacter baumannii harboring the OXA-23 carbapenemase in intensive care units of Egyptian hospitals. Int J Infect Dis 17 (2013), e1252–e1254.
27. 27 Zowawi, H.M., Sartor, A.L., Sidjabat, H.E., Balkhy, H.H., Walsh, T.R., Al Johani, S.M., et al. Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii isolates in the Gulf Cooperation Council States: dominance of OXA-23-type producers. J Clin Microbiol 53 (2015), 896–903.
28. 28 Merino, M., Poza, M., Roca, I., Barba, M.J., Sousa, M.D., Vila, J., et al. Nosocomial outbreak of a multiresistant Acinetobacter baumannii expressing OXA-23 carbapenemase in Spain. Microb Drug Resist 20 (2014), 259–263.
29. 29 Salimizand, H., Noori, N., Meshkat, Z., Ghazvini, K., Amel, S.J., Prevalence of Acinetobacter baumannii harboring ISAba1/bla OXA-23-like family in a burn center. Burns J Int Soc Burn Inj 41 (2015), 1100–1106.
30. 30 Rafei, R., Dabboussi, F., Hamze, M., Eveillard, M., Lemarié, C., Mallat, H., et al. First report of blaNDM-1-producing Acinetobacter baumannii isolated in Lebanon from civilians wounded during the Syrian war. Int J Infect Dis 21 (2014), 21–23.
31. 31 Al Atrouni, A., Joly-Guillou, M.L., Hamze, M., Kempf, M., Emergence of NDM-1 and OXA-72 producing Acinetobacter pittii clinical isolates in Lebanon. New Microbes New Infect 12 (2016), 43–44.
32. 32 Karah, N., Sundsfjord, A., Towner, K., Samuelsen, Ø., Insights into the global molecular epidemiology of carbapenem non-susceptible clones of Acinetobacter baumannii. Drug Resist Updat 15 (2012), 237–247.
33. 33 Huber, C.A., Sartor, A.L., McOdimba, F., Shah, R., Shivachi, P., Sidjabat, H.E., et al. Outbreaks of multidrug-resistant Acinetobacter baumannii strains in a Kenyan teaching hospital. J Glob Antimicrob Resist 2 (2014), 190–193.
34. 34 Giannouli, M., Antunes, L.C., Marchetti, V., Triassi, M., Visca, P., Zarrilli, R., Virulence-related traits of epidemic Acinetobacter baumannii strains belonging to the international clonal lineages I–III and to the emerging genotypes ST25 and ST78. BMC Infect Dis, 13, 2013, 282.
35. 35 Villalón, P., Valdezate, S., Medina-Pascual, M.J., Rubio, V., Vindel, A., Saez-Nieto, J.A., Clonal diversity of nosocomial epidemic Acinetobacter baumannii strains isolated in Spain. J Clin Microbiol 49 (2011), 875–882.
36. 36 Decousser, J.W., Jansen, C., Nordmann, P., Emirian, A., Bonnin, R.A., Anais, L., et al. Outbreak of NDM-1-producing Acinetobacter baumannii in France, January to May 2013. Euro Surveill, 18(31), 2013 pii: 20547.
37. 37 Heydari, F., Mammina, C., Koksal, F., NDM-1-producing Acinetobacter baumannii ST85 now in Turkey, including one isolate from a Syrian refugee. J Med Microbiol 64 (2015), 1027–1029.
38. 38 Wright, M.S., Haft, D.H., Harkins, D.M., Perez, F., Hujer, K.M., Bajaksouzian, S., et al. New insights into dissemination and variation of the health care-associated pathogen Acinetobacter baumannii from genomic analysis. mBio, 5, 2014 e00963-e00913.
39. 39 El-Shazly, S., Dashti, A., Vali, L., Bolaris, M., Ibrahim, A.S., Molecular epidemiology and characterization of multiple drug-resistant (MDR) clinical isolates of Acinetobacter baumannii. Int J Infect Dis 41 (2015), 42–49.
40. 40 O'Shea, M.K., Acinetobacter in modern warfare. Int J Antimicrob Agents 39 (2012), 363–375.